Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

The committee has been investigating allegations that Mr. Gaetz, President-elect Donald J. Trump’s pick for attorney general, ...

The House speaker said revealing the findings of a yearslong inquiry into allegations of sexual misconduct and drug use would ...

Trump's AG nominee resigned from Congress days before the committee was set to release the findings of its probe into ...

The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...

Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...

This study introduces a novel lignin-based hydrogel with controlled release and enhanced mechanical strength, leveraging ...

Jaguar Health announced that its product, cofelemer delayed-release tablets (Canalevia-CA1; Jaguar Health), received approved ...

Before you add some cinnamon to your holiday baked goods, you should check to see if your cinnamon has been recalled. The ...

In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...

With a federal grant in hand, researchers at the health system and national lab will try to hit fast forward on the long and ...